Preclinical Investigation of Immune Checkpoint Blockade and Anti-Angiogenic Therapy in Malignant Pleural Mesothelioma

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S325-S325
Number of pages	1
Journal	Journal of Thoracic Oncology
Volume	17
Issue number	9
Publication status	Published - Sept 2022

Cite this

@article{9c341eee28d04d6aa9da5d6f1ce9d43e,

title = "Preclinical Investigation of Immune Checkpoint Blockade and Anti-Angiogenic Therapy in Malignant Pleural Mesothelioma",

keywords = "Malignant pleural mesothelioma, Immune checkpoint blockade, Anti-angiogenesis",

author = "S. Rovers and C. Merlin and S. Fisher and A. Nowak and P. Pauwels and F. Lardon and \{Van Meerbeeck\}, J. and E. Smits and E. Marcq",

year = "2022",

month = sep,

language = "English",

volume = "17",

pages = "S325--S325",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - Preclinical Investigation of Immune Checkpoint Blockade and Anti-Angiogenic Therapy in Malignant Pleural Mesothelioma

AU - Rovers, S.

AU - Merlin, C.

AU - Fisher, S.

AU - Nowak, A.

AU - Pauwels, P.

AU - Lardon, F.

AU - Van Meerbeeck, J.

AU - Smits, E.

AU - Marcq, E.

PY - 2022/9

Y1 - 2022/9

KW - Malignant pleural mesothelioma

KW - Immune checkpoint blockade

KW - Anti-angiogenesis

M3 - Abstract/Meeting Abstract

SN - 1556-0864

VL - 17

SP - S325-S325

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 9

ER -